For decades, endometriosis has been underfunded, misunderstood, and undertreated. New science is changing that. Here is why the $220 billion endometriosis market represents one of the most compelling opportunities in medicine today.

Sur180 Therapeutics and Nura Health announce strategic partnership to advance endometriosis diagnostics and non-hormonal treatment.